Catalyst Wire Dossier Catalyst Wire Dossier

Respicardia Therapy

· Respicardia, Inc.
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Respicardia Therapy, covering 2015-08-31 to 2015-08-31. Get the full timeline:

Most recent: Clinical Trial Update: Chronic Evaluation of Respicardia Therapy [Phase 2]

See pricing